Effect of combined treatment of radiation and tissue-specific recombinant oncolytic adenovirus on bladder cancer cells. (1st February 2017)
- Record Type:
- Journal Article
- Title:
- Effect of combined treatment of radiation and tissue-specific recombinant oncolytic adenovirus on bladder cancer cells. (1st February 2017)
- Main Title:
- Effect of combined treatment of radiation and tissue-specific recombinant oncolytic adenovirus on bladder cancer cells
- Authors:
- Zhang, Hongjuan
Wang, Fang
Mao, Chunjie
Zhang, Zuncheng
Fu, Shengjun
Lu, Jianzhong
Zhai, Zhenxing
Li, Renju
Li, Shuwen
Rodriguez, Ron
Wang, Zhiping - Abstract:
- Abstract: Purpose: Gene therapy combined with radiation has shown promising potential for the treatment of tumors. This paper aimed to clarify the synergistic effect of radiotherapy combined with the bladder cancer tissue-specific oncolytic adenovirus (Ad-PSCAE-UPII-E1A) on bladder cancer cells and to study the underlying synergy mechanisms of the combined treatment. Materials and methods: The Adenovirus carrying E1A under control of UPII promoter and prostate stem cell antigen enhancer (PSCAE) were successfully constructed. The viability of bladder cancer cells BIU-87 and EJ was determined by MTT assay. The apoptotic assay was demonstrated by flow cytometry and TEM. Virus titer was determined by TCID50 assay, and proteins Mre11, Chk2-Thr68, and E1A were analyzed by Western blot method. Results: Oncolytic adenovirus combined with radiotherapy improved antitumor efficacy compared with the single treatment at a time and was X-ray dosage-dependent. When the adenovirus infection was scheduled at 24 h after irradiation, cancer cells had the lowest viability. Adenovirus and irradiation induced cell death through the caspase-3 related apoptotic pathway, and bladder cancer cells were arrested at the G1 (BIU-87) or S phase (EJ). Autophagic vacuoles were observed in bladder cancer cells treated with radiation and adenovirus. After irradiation, more virus particles were observed in the BIU-87 and EJ cells. However, by a TCID50 assay, there was no difference in virus titter betweenAbstract: Purpose: Gene therapy combined with radiation has shown promising potential for the treatment of tumors. This paper aimed to clarify the synergistic effect of radiotherapy combined with the bladder cancer tissue-specific oncolytic adenovirus (Ad-PSCAE-UPII-E1A) on bladder cancer cells and to study the underlying synergy mechanisms of the combined treatment. Materials and methods: The Adenovirus carrying E1A under control of UPII promoter and prostate stem cell antigen enhancer (PSCAE) were successfully constructed. The viability of bladder cancer cells BIU-87 and EJ was determined by MTT assay. The apoptotic assay was demonstrated by flow cytometry and TEM. Virus titer was determined by TCID50 assay, and proteins Mre11, Chk2-Thr68, and E1A were analyzed by Western blot method. Results: Oncolytic adenovirus combined with radiotherapy improved antitumor efficacy compared with the single treatment at a time and was X-ray dosage-dependent. When the adenovirus infection was scheduled at 24 h after irradiation, cancer cells had the lowest viability. Adenovirus and irradiation induced cell death through the caspase-3 related apoptotic pathway, and bladder cancer cells were arrested at the G1 (BIU-87) or S phase (EJ). Autophagic vacuoles were observed in bladder cancer cells treated with radiation and adenovirus. After irradiation, more virus particles were observed in the BIU-87 and EJ cells. However, by a TCID50 assay, there was no difference in virus titter between irradiated bladder cancer cells and unirradiated cells. The proteins Mre11, Chk2-Thr68 which involved in the DNA break repair pathway were decreased while γ-H2AX-Ser139 increased; at the same time, the E1A gene and the hexon proteins of oncolytic adenovirus were increased after irradiation. Conclusions: Our results proved synergistic antitumor effect of adenovirus Ad-PSCAE-UPII-E1A and radiation, which might be a potential therapeutic strategy for bladder cancer. … (more)
- Is Part Of:
- International journal of radiation biology. Volume 93:Number 2(2017:Feb.)
- Journal:
- International journal of radiation biology
- Issue:
- Volume 93:Number 2(2017:Feb.)
- Issue Display:
- Volume 93, Issue 2 (2017)
- Year:
- 2017
- Volume:
- 93
- Issue:
- 2
- Issue Sort Value:
- 2017-0093-0002-0000
- Page Start:
- 174
- Page End:
- 183
- Publication Date:
- 2017-02-01
- Subjects:
- Bladder cancer -- gene therapy -- oncolytic adenovirus -- radiation therapy
Radiation -- Physiological effect -- Periodicals
Radiobiology -- Periodicals
571.45 - Journal URLs:
- http://www.tandfonline.com/loi/irab20 ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/09553002.2017.1231942 ↗
- Languages:
- English
- ISSNs:
- 0955-3002
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.517900
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 29.xml